Thermo Fisher offers animal origin-free formulation to support scaling of cell therapy manufacturing
India, April 15 -- US-based Thermo Fisher Scientific Inc. has introduced theGibco CTS OpTmizer One Serum-Free Medium(CTS OpTmizer One SFM), a novel animal origin-free (AOF) formulation designed specifically for clinical and commercial cell therapy manufacturing to deliver increased scalability and performance of T-cell expansion. As a result, cell therapy manufacturers can use CTS OpTmizer One SFM to help optimise their workflows and get T-cell therapies to patients faster.
CTS OpTmizer One SFM's ready-to-use, one-part medium can help cell therapy manufacturers scale their manufacturing from process development to clinical trials and commercial manufacturing while maintaining consistent performance. As part of the cell expansion process,...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.